S Homma

Summary

Affiliation: Louisiana State University Health Sciences Center
Country: USA

Publications

  1. ncbi Carotid plaque and intima-media thickness assessed by b-mode ultrasonography in subjects ranging from young adults to centenarians
    S Homma
    Department of Internal Medicine, Kugayama Hospital, Tokyo, Japan
    Stroke 32:830-5. 2001
  2. ncbi Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model
    Y Akasaki
    Department of Neurosurgery, Jikei University School of Medicine, Tokyo, Japan
    J Immunother 24:106-13. 2001
  3. ncbi Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses
    S Homma
    Department of Oncology, Institute of DNA Medicine, Jikei University School of Medicine, Nishi Shimbashi, Tokyo, Japan
    Clin Exp Immunol 144:41-7. 2006
  4. ncbi Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
    T Kikuchi
    Department of Oncology, The Institute of DNA Medicine, Jikei University, Tokyo, Japan
    Cancer Immunol Immunother 50:337-44. 2001
  5. ncbi Antigenic stimulation with cytochrome P450 2J expressed in mouse hepatocellular carcinoma cells regulates host anti-tumour immunity
    S Homma
    Departments of Oncology, Institute of DNA Medicine, Jekei University School of Medicine, Tokyo, Japan
    Clin Exp Immunol 156:344-52. 2009
  6. ncbi Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice
    S Homma
    Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan
    J Gastroenterol 36:764-71. 2001
  7. ncbi Histopathological modifications of early atherosclerotic lesions by risk factors--findings in PDAY subjects
    S Homma
    Department of Internal Medicine, Kugayama Hospital, 2 14 20, Kitakarasuyama, Setagaya Ku, 157 0061, Tokyo, Japan
    Atherosclerosis 156:389-99. 2001
  8. ncbi Activated natural killer T cells producing interferon-gamma elicit promoting activity to murine dendritic cell-based autoimmune hepatic inflammation
    M Nakano
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan
    Clin Exp Immunol 170:274-82. 2012
  9. ncbi Cancer immunotherapy by fusions of dendritic and tumour cells and rh-IL-12
    S Homma
    Jikei University School of Medicine, Tokyo, Japan
    Eur J Clin Invest 35:279-86. 2005
  10. ncbi Pseudoaldosteronism with increased serum cortisol associated with pneumonia, hypouricemia, hypocalcemia, and hypophosphatemia
    A Onishi
    Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan
    Clin Nephrol 74:403-8. 2010

Detail Information

Publications13

  1. ncbi Carotid plaque and intima-media thickness assessed by b-mode ultrasonography in subjects ranging from young adults to centenarians
    S Homma
    Department of Internal Medicine, Kugayama Hospital, Tokyo, Japan
    Stroke 32:830-5. 2001
    ....
  2. ncbi Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model
    Y Akasaki
    Department of Neurosurgery, Jikei University School of Medicine, Tokyo, Japan
    J Immunother 24:106-13. 2001
    ..These data support the therapeutic efficacy of combining FC-based vaccine therapy and rIL-12...
  3. ncbi Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses
    S Homma
    Department of Oncology, Institute of DNA Medicine, Jikei University School of Medicine, Nishi Shimbashi, Tokyo, Japan
    Clin Exp Immunol 144:41-7. 2006
    ..Elevated serum levels of ANA after DC/tumour-fusion cell vaccine might be associated with anti-tumour immune response induced by the vaccination...
  4. ncbi Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
    T Kikuchi
    Department of Oncology, The Institute of DNA Medicine, Jikei University, Tokyo, Japan
    Cancer Immunol Immunother 50:337-44. 2001
    ..we were unable to establish a statistically significant treatment-associated response rate, due to the limited sample population. Therefore, further evaluation of the role of adjuvant cytokines is necessary...
  5. ncbi Antigenic stimulation with cytochrome P450 2J expressed in mouse hepatocellular carcinoma cells regulates host anti-tumour immunity
    S Homma
    Departments of Oncology, Institute of DNA Medicine, Jekei University School of Medicine, Tokyo, Japan
    Clin Exp Immunol 156:344-52. 2009
    ....
  6. ncbi Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice
    S Homma
    Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan
    J Gastroenterol 36:764-71. 2001
    ..CONCLUSIONS: These results demonstrate that immunization with fusions of DCs and HCC cells is capable of inducing preventive antitumor immunity against HCC...
  7. ncbi Histopathological modifications of early atherosclerotic lesions by risk factors--findings in PDAY subjects
    S Homma
    Department of Internal Medicine, Kugayama Hospital, 2 14 20, Kitakarasuyama, Setagaya Ku, 157 0061, Tokyo, Japan
    Atherosclerosis 156:389-99. 2001
    ..Smokers had less number of foam cells in both the arteries and more intensive intimal fibrosis in LAD than non-smokers. Our study suggests that there are several ways to advanced atherosclerotic lesions by risk factors...
  8. ncbi Activated natural killer T cells producing interferon-gamma elicit promoting activity to murine dendritic cell-based autoimmune hepatic inflammation
    M Nakano
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan
    Clin Exp Immunol 170:274-82. 2012
    ..Activated NK T cells producing IFN-γ potentiate DC-based AHI in the mouse model...
  9. ncbi Cancer immunotherapy by fusions of dendritic and tumour cells and rh-IL-12
    S Homma
    Jikei University School of Medicine, Tokyo, Japan
    Eur J Clin Invest 35:279-86. 2005
    ..We conducted immunotherapy against various malignant tumours using the FCs and rhIL-12, and investigated the safety and efficacy of the therapy...
  10. ncbi Pseudoaldosteronism with increased serum cortisol associated with pneumonia, hypouricemia, hypocalcemia, and hypophosphatemia
    A Onishi
    Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan
    Clin Nephrol 74:403-8. 2010
    ..In this patient, the increased circulating cortisol associated with the stress of inflammation caused by pneumonia triggered the development of pseudoaldosteronism...
  11. ncbi Repeated administration of cytokines improve the ex-vivo generation of human dendritic cells
    A Takeda
    Dept. of Oncology, Institute of DNA Medicine, Jikei University, School of Medicine, Tokyo, Japan
    J Exp Clin Cancer Res 23:617-23. 2004
    ..As a prototype of cell therapy, the generation of DCs will require a titration of differentiation processes, depending on each individual's responsiveness to cytokines...
  12. ncbi Lipoprotein metabolism in Japanese centenarians: effects of apolipoprotein E polymorphism and nutritional status
    Y Arai
    Department of Geriatric Medicine, Keio University School of Medicine, Tokyo, Japan
    J Am Geriatr Soc 49:1434-41. 2001
    ..To assess the complex interaction of apolipoprotein (apo) E polymorphisms and environmental factors on lipoprotein profile in centenarians...
  13. ncbi Effects of long-term, low-fat diet on plasma apo E in familial LCAT deficiency
    S Homma
    Department of Internal Medicine, Jichi Medical School, Tochigi, Japan
    Nihon Jinzo Gakkai Shi 35:999-1006. 1993
    ..A low-fat diet may be effective in correcting lipid abnormalities. Moreover, plasma apo E may be a good indicator of the efficacy of diet therapy...